Modern etiotropic therapy of chronic viral hepatitis B

Modern etiotropic therapy of chronic viral hepatitis B

Chronic viral hepatitis B (CHB) is a significant global health problem. The biological characteristics of the hepatitis B virus, which causes this disease, significantly impede the achievement of complete virus elimination in most patients. In this regard, the rational choice of drugs and antiviral...

Full description

Bibliographic Details
Main Authors:	E. B. Bun'kova, N. A. Bileva, A. E. Bilev, M. I. Sinel'nikov
Format:	Article
Language:	Russian
Published:	Private institution educational organization of higher education "Medical University "ReaViz" 2024-10-01
Series:	Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:	chronic viral hepatitis b hepatitis b virus interferons nucleoside/nucleotide analogs etiotropic therapy antiviral therapy
Online Access:	https://vestnik.reaviz.ru/jour/article/view/1028

Similar Items

The feasibility of pathogenetic therapy for chronic viral hepatitis C in adult HIV-infected patients
by: E. B. Bun'kova, et al.
Published: (2024-09-01)

ETIOTROPIC THERAPY OF VIRAL HEPATITIS
by: S. B. Chuelov, et al.
Published: (2017-09-01)

Towards the elimination and eradication of hepatitis B
by: Geoffrey Dusheiko
Published: (2015-01-01)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
by: Erik De Clercq, et al.
Published: (2010-05-01)

Modern modes of chronic hepatitis B treatment in daily clinical practice
by: M. V. Mayevskaya, et al.
Published: (2014-11-01)

A new approach to etiotropic therapy ARVI in children
by: Alebai U. Sabitov, et al.
Published: (2022-12-01)

Clinical Utility of Quantitative Hbsag in Chronic Hepatitis B Infection
by: Poernomo Boedi Setiawan, et al.
Published: (2020-07-01)

EFFECTIVE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS B IN THE CONTEMPORARY PRACTICE OF HEPATOLOGY
by: R. G. MYAZIN
Published: (2017-05-01)

The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection
by: D. A. Lioznov, et al.
Published: (2020-12-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

CURRENT ASPECTS OF ETIOTROPIC COVID-19 THERAPY
by: D. N. Zemskov, et al.
Published: (2022-12-01)

Hepatitis B viral factors and treatment responses in chronic hepatitis B
by: Chih-Lin Lin, et al.
Published: (2013-06-01)

Distinct histological patterns in chronic hepatitis D with nucleos(t)ide analogue therapy
by: Julian Hercun, et al.
Published: (2023-04-01)

Antiviral efficacy of entecavir for hepatitis B virus rtA181V/T mutants
by: Ping Li, et al.
Published: (2017-04-01)

Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs
by: Ziqiang Xia, et al.
Published: (2021-10-01)

Efficacy of antiviral therapy in the treatment of severe forms of acute hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-02-01)

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
by: Hyung Joon Yim, et al.
Published: (2013-09-01)

Chronic hepatitis B and risk of kidney involvement
by: M. V. Mayevskaya, et al.
Published: (2013-05-01)

Influenza B Virus: Some Features of Clinical Findings and Etiotropic Treatment
by: O. V. Maltsev, et al.
Published: (2014-09-01)

Efficacy and its Predictors of Antiviral Therapy with Nucleos(T)Ide Analogs in Patients with Chronic Hepatitis B
by: T. H. Nguyen, et al.
Published: (2024-04-01)

The Study of Clinical and Biochemical Parameters in Assessing the Response to the Antiviral Therapy in the Chronic Viral Hepatitis B
by: Alice Elena Ghenea, et al.
Published: (2021-07-01)

The course and treatment of chronic hepatitis B in HIV-infected patients
by: Semen Leonidovich Maksimov, et al.
Published: (2010-11-01)

COVID-19: аn Update on the Modern Etiotropic Therapy Methods for the New Coronavirus Infection
by: Evgeny A. Sinitsyn, et al.
Published: (2023-10-01)

Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion
by: Ganesh Selvaraj Duraisamy, et al.
Published: (2022-09-01)

Vertical transmission of hepatitis B: the real and imaginary danger
by: M. A. Belopolskaya
Published: (2015-04-01)

A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure
by: Wei Lin, et al.
Published: (2018-05-01)

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)

Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
by: Jian-Hua Lei, et al.
Published: (2019-04-01)

Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
by: Cesar Henriquez-Camacho, et al.
Published: (2023-11-01)

External otitis: from differential diagnostics to etiotropic therapy
by: V. M. Svistushkin, et al.
Published: (2016-12-01)

Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B
by: Wang L, et al.
Published: (2018-11-01)

Plasmacytoid dendritic cells and their role in the immunopathogenesis of viral infections for example hepatitis B
by: R. R. Khodzhibekov, et al.
Published: (2019-05-01)

What’s new in the etiotropic therapy of coronavirus infection?
by: A. V. Budnevsky
Published: (2022-10-01)

EVOLUTION OF THE ETIOTROPIC TREATMENT OF SHIGELLOSIS
by: V. V. NIKIFOROV, et al.
Published: (2017-05-01)

Endogenous retrovirus: from fundamental studies to etiotropic therapy of multiple sclerosis
by: M. N. Zakharova, et al.
Published: (2017-02-01)

Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice
by: Yan Liu, et al.
Published: (2019-01-01)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
by: Vicente Soriano, et al.
Published: (2022-01-01)

A recurrence of Guillain-Barr and eacute; syndrome or a case of acute-onset chronic inflammatory demyelinating polyneuropathy in the course of chronic hepatitis B?
by: Guner Celik Koyuncu, et al.
Published: (2016-12-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01)